Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Gastroenterology|July 21, 2025
The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype-phenotype studyJaejun Lee, Jung Hoon Cha, Hee Sun Cho, et al.
Diabetes & Metabolism Journal|June 10, 2026
Fibroblast- and Macrophage-Derived Thrombospondin-1 Orchestrates the Fibroinflammatory Niche in Metabolic Dysfunction-Associated Steatohepatitis-Induced FibrosisSung Woo Cho, Jung Hoon Cha, Deok Wha Seo, et al.
Radiology|August 4, 2026
Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular CarcinomaJae-Sung Yoo, Kwon Yong Tak, Hee Sun Cho, et al.
Liver Cancer|March 27, 2025
Dynamic Peripheral T-Cell Analysis Identifies On-Treatment Prognostic Biomarkers of Atezolizumab plus Bevacizumab in Hepatocellular CarcinomaJi Won Han, Min Woo Kang, Soon Kyu Lee, et al.
Cancers|September 9, 2023
Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score StudyJi Hoon Kim, Hee-Chul Nam, Chang-Wook Kim, et al.
Frontiers in Oncology|March 14, 2024
Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative studyJi Won Han, Pil Soo Sung, Jae-Sung Yoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2025
Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and BevacizumabJaejun Lee, Keungmo Yang, Ji Won Han, et al.
NPJ Digital Medicine|May 21, 2026
Machine learning based hepatic safety score predicts decompensation in hepatocellular carcinoma systemic therapyJi Won Han, Jaejun Lee, Keungmo Yang, et al.
Liver Cancer|March 19, 2026
Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic TreatmentsJaejun Lee, Hyun Yang, Si Hyun Bae, et al.
Hepatology (Baltimore, Md.)|June 30, 2025
Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumabHeechul Nam, Dong Yun Kim, Do Young Kim, et al.
Pageof 2